Rankings
▼
Calendar
IRD Q3 2020 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena
IRD
Opus Genetics, Inc.
$346M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$2M
Net Income
-$1M
EPS (Diluted)
$-0.18
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$616,000
← FY 2020
All Quarters
Q4 2020 →
